Founder, Chairman of the Board

Iantrek raises $42M for Alloflo Uveo glaucoma therapy launch

Iantrek Raises $42M in Series C for Glaucoma Treatment Device

Iantrek: $42 Million Series C Raised For Interventional Glaucoma Therapy

Iantrek Raises $42 Million Series C

Regional Sales Director - Central

IANTREK is dedicated to innovation in glaucoma care, developing advanced technologies for chronic eye disease management. The Regional Sales Director will lead the ophthalmic surgical portfolio expansion, manage a team of Surgical Glaucoma Managers, and drive commercial growth while fostering partnerships with key stakeholders.

Sign up with Google

Sign in with Google